Hepatitis B vaccine recombinant - Combiotech
Latest Information Update: 08 Dec 1998
At a glance
- Originator Combiotech
- Class Hepatitis B vaccines; Synthetic vaccines
- Mechanism of Action Immunostimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Marketed Hepatitis B
Most Recent Events
- 26 Jul 1996 Launched for Hepatitis B in Russia (IM)